Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
TRIMTECH Therapeutics raises $31M seed funding to advance targeted protein degradation pipeline for treatment of neurodegenerative diseases
Life Sciences Times
-
March 5, 2025
0
Venture Capital
Oklo Closes Acquisition of Radioisotope Producer Atomic Alchemy
Life Sciences Times
-
March 5, 2025
0
Venture Capital
CIBC Innovation Banking supports MediSpend’s acquisition of Real Life Sciences
Life Sciences Times
-
March 4, 2025
0
Venture Capital
Demetra Holding Spa Acquires Majority Stake in Swiss-based GetSet Surgical, Expanding Strategic Portfolio in the Spine Sector
Life Sciences Times
-
February 27, 2025
0
Venture Capital
Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio
Life Sciences Times
-
February 24, 2025
0
Venture Capital
XRHealth Acquires Immersive, Digital Therapeutics Company RealizedCare, Creating the Largest AI-Driven Therapeutic XR Platform Globally
Life Sciences Times
-
February 18, 2025
0
Venture Capital
MMS Acquires Exploristics and KerusCloud Simulation Platform to Expand Biostatistics and Data Science Capabilities as a Global Data-Focused CRO
Life Sciences Times
-
February 12, 2025
0
Venture Capital
TECLens Secures $9.3 Million Series A Funding to Advance Its Non-Invasive Refractive Technology
Life Sciences Times
-
February 11, 2025
0
Venture Capital
Blackstone Life Sciences and Anthos Therapeutics Announce Agreement for Anthos to be Acquired by Novartis for up to $3.1 Billion
Life Sciences Times
-
February 11, 2025
0
Venture Capital
AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing
Life Sciences Times
-
February 3, 2025
0
Venture Capital
AVS Completes a $36M Series B Financing Ahead of IVL U.S. Commercial Launch
Life Sciences Times
-
January 28, 2025
0
Venture Capital
Alleviant Medical Secures $90 Million Financing to Expand Interventional Heart Failure Pivotal Trial Program
Life Sciences Times
-
January 14, 2025
0
1
...
20
21
22
...
115
Page 21 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026